Corrigendum to ''A glucose-targeted mixed micellar formulation outperforms Genexol in breast cancer cells'' [Euro. J. Pharmaceut. Biopharmaceut. 114 (2017) 305-316].

Marcela A Moretton Ezequiel Bernabeu Estefanía Grotz Lorena Gonzalez Marcela Zubillaga Diego A Chiappetta

Eur J Pharm Biopharm

Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Cátedra de Tecnología Farmacéutica I, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Argentina. Electronic address:

Published: October 2017

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ejpb.2017.07.008	DOI Listing

Publication Analysis

Top Keywords

corrigendum ''a

''a glucose-targeted

glucose-targeted mixed

mixed micellar

micellar formulation

formulation outperforms

outperforms genexol

genexol breast

breast cancer

cancer cells''

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!